Frontiers in GeneticsGeneticsPeer-reviewed journal article
Intra-familial phenotypic heterogeneity and telomere abnormality in von Hippel-Lindau disease
Jiangyi WangiD, Xiang Peng, Cen CheniD, Xianghui NingiD, Shuanghe Peng, Teng LiiD, Shengjie LiuiD, Baoan HongiD, Jingcheng ZhouiD, Kaifang MaiD, Lin CaiiD, Kan GongiD
- Citations
- 8
- FWCI
- 0.74
- Field percentile
- top 28%
Abstract
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome with poor survival. The current recommendations have proposed uniform surveillance strategies for all patients, neglecting the obvious phenotypic varieties. In this study, we aim to confirm the phenotypic heterogeneity in VHL disease and the underlying mechanism. A total of 151 parent-child pairs were enrolled for genetic anticipation analysis, and 77 sibling pairs for birth order effect analysis. Four statistical methods were used to compare the onset age of patients among different generations and different birth orders. The results showed that the average onset age was 18.9 years earlier in children than in their parents, which was statistically significant in all of the four statistical methods. Furthermore, the first-born siblings were affected 8.3 years later than the other ones among the maternal patients. Telomere shortening was confirmed to be associated with genetic anticipation in VHL families, while it failed to explain the birth order effect. Moreover, no significant difference was observed for overall survival between parents and children (p=0.834) and between first-born patients and the other siblings (p=0.390). This study provides definitive evidence and possible mechanisms of intra-familial phenotypic heterogeneity in VHL families, which is helpful to the update of surveillance guidelines.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In Silico Analysis of Novel VHL Germline Mutations in Iranian RCH Patients
Masood Naseripour, Kowsar Bagherzadeh, … Fatemeh Azimi·bioRxiv·Oct 26, 2022
- Algorithmic Assessment of Missense Mutation Severity in the Von-Hippel Lindau Protein
- Genotype-Phenotype Relations of the von Hippel-Lindau Tumor Suppressor Inferred from a Large-Scale Analysis of Disease Mutations and Interactors
G. Minervini, F. Quaglia, … S. C. E. Tosatto·bioRxiv·Aug 31, 2018
- Pharmacological Restoration of Visual Function in a Zebrafish Model of von-Hippel Lindau Disease
R. Ward, K. Slater, … B. N. Kennedy·bioRxiv·Dec 4, 2018
- Multi-Platform Curation in the Development of ACMG/AMP Specifications for Von Hippel Lindau (VHL) Disease
Deborah Ritter, Chansonette Badduke, … Raymond H. Kim·Genetics in MedicinePeer-reviewed·May 1, 2026
- HNRNPC-mediated RNA processing promotes VHL-associated excessive vasculogenesis in von Hippel-Lindau syndrome revealed from patient-derived blood vessel models
Hidenori Ito, Iori Sato, … Yohei Hayashi·bioRxiv·Nov 2, 2026